Privia Health Group, Inc. (PRVA) FY2025 10-K Annual Report
Privia Health Group, Inc. (PRVA) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 27, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Privia Health Group, Inc. FY2025 10-K Analysis
Business Overview
- • Core business: technology-driven physician enablement platform combining regional medical group partnership with provider autonomy, focused on value-based care (VBC) and provider workflow optimization
- • New emphasis: expansion of Privia Women’s Health and Pediatrics platforms and growth in virtual health services (4.7M virtual visits by 1.5M patients in 2025)
Management Discussion & Analysis
- • Operating lease expense $3.2M in 2025 vs $2.8M in 2024 and $2.7M in 2023
- • Administrative service rebates $3.5M in 2025, $1.8M in 2024, $2.7M in 2023
Risk Factors
- • Cybersecurity incident risk with potential to compromise patient and business data, cause operational disruption, and trigger costly remediation and liability
- • Board-level oversight of cybersecurity risks involving CISO with 15+ years health IT leadership, ensuring monthly updates to executive leadership
Privia Health Group, Inc. FY2025 Key Financial MetricsXBRL
Revenue
$2.1B
▲ +22.3% YoY
Net Income
$23M
▲ +59.3% YoY
Operating Margin
1.6%
▲ +63bp YoY
Net Margin
1.1%
▲ +25bp YoY
ROE
3.1%
▲ +84bp YoY
Total Assets
$1.4B
▲ +20.6% YoY
EPS (Diluted)
$0.18
▲ +63.6% YoY
Operating Cash Flow
$163M
▲ +49.5% YoY
Source: XBRL data from Privia Health Group, Inc. FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Privia Health Group, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.